Author:
Gao Yanhui,Liu Ruichen,Gautam Nagsen,Ma Bowen,Xie Zhiyu,Sun Bin,Zheng Hongbo,Liu Dongke,Lou Hongxiang
Funder
Open Project of Shandong Provincial (China) Key Laboratory of Reproductive Medicine
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference28 articles.
1. Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II;Xue;Invest. New Drugs,2012
2. Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents;Jiang;Bioorg. Med. Chem.,2012
3. Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma;Sun;Eur. J. Pharmacol.,2011
4. Riccardin d, a macrocyclic bisbibenzy, inhibits human breast Cancer growth through the suppression of telomerase activity;Sun;Basic Clin. Pharmacol. Toxicol.,2014
5. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way;Yue;Cancer Lett.,2013
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献